TherapeuticsMD (TXMD) Total Debt Growth (1y) (2011 - 2022)
TherapeuticsMD (TXMD) Total Debt Growth (1y) (2011 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -11.90% |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -0.14% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 37.52% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -10.56% |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -9.53% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -13.33% |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -49.88% |
| Jun 30, 2022 | -51.00% |
| Mar 31, 2022 | 7.35% |
| Dec 31, 2021 | -20.79% |
| Sep 30, 2021 | -21.22% |
| Jun 30, 2021 | -24.01% |
| Mar 31, 2021 | -22.37% |
| Dec 31, 2020 | 22.13% |
| Sep 30, 2020 | 21.96% |
| Jun 30, 2020 | 25.61% |
| Mar 31, 2020 | 231.19% |
| Dec 31, 2019 | 165.24% |
| Sep 30, 2019 | 165.30% |
| Jun 30, 2019 | 165.37% |
| Mar 31, 2013 | -95.48% |
| Dec 31, 2012 | 33.72% |
| Dec 31, 2011 | 1,178.17% |